Peterlabs Holdings Bhd (XKLS:0171) Altman Z2-Score: 5.46 (As of Jun. 29, 2026) — 20% Below Median


XKLS:0171 Peterlabs Holdings Bhd XKLS:0171
47 GF Score
Price RM0.24
GF Value RM0.20
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Peterlabs Holdings Bhd Altman Z2-Score?

Peterlabs Holdings Bhd XKLS:0171 47 Altman Z2-Score is 5.46 as of Jun. 29, 2026, which is 20% below its 10-year median of 6.81. GuruFocus rates XKLS:0171 with a GF Score™ of 47/100 and a GF Value™ of RM0.20 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 994 Drug Manufacturers companies, Peterlabs Holdings Bhd ranks better than 64.29% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Good Sign:

Peterlabs Holdings Bhd has a Altman Z2-Score of 5.46, indicating it is in Safe Zones. This implies the Altman Z2-Score is strong.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Peterlabs Holdings Bhd's Altman Z2-Score or its related term are showing as below:

XKLS:0171' s Altman Z2-Score Range Over the Past 10 Years
Min: 5.41   Med: 6.81   Max: 9.75
Current: 5.46

During the past 13 years, Peterlabs Holdings Bhd's highest Altman Z2-Score was 9.75. The lowest was 5.41. And the median was 6.81.


Peterlabs Holdings Bhd  (XKLS:0171) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Peterlabs Holdings Bhd Altman Z2-Score Related Terms


Peterlabs Holdings Bhd Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Peterlabs Holdings Bhd's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Peterlabs Holdings Bhd Altman Z2-Score Chart

Peterlabs Holdings Bhd Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z2-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.78 9.75 6.49 7.25 6.25

Peterlabs Holdings Bhd Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.02 6.44 5.92 6.78 5.46

XKLS:0171 vs ZTS, UTHR, VTRS: Altman Z2-Score Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Peterlabs Holdings Bhd's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Peterlabs Holdings Bhd Altman Z2-Score vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Peterlabs Holdings Bhd's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Peterlabs Holdings Bhd's Altman Z2-Score falls into.


XKLS:0171
47GF Score
Peterlabs Holdings Bhd XKLS:0171
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Peterlabs Holdings Bhd Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Peterlabs Holdings Bhd's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.3028+3.26*0.3253+6.72*0.0151+1.05*2.2027
=5.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Jun. 2025:
Total Assets was RM112.2 Mil.
Total Current Assets was RM67.2 Mil.
Total Current Liabilities was RM33.2 Mil.
Retained Earnings was RM36.5 Mil.
Pre-Tax Income was -1.831 + 1.16 + 0.46 + 1.228 = RM1.0 Mil.
Interest Expense was -0.168 + -0.147 + -0.171 + -0.191 = RM-0.7 Mil.
Total Liabilities was RM34.9 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(67.159 - 33.199)/112.152
=0.3028

X2=Retained Earnings/Total Assets
=36.484/112.152
=0.3253

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(1.017 - -0.677)/112.152
=0.0151

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(76.885 - 0)/34.905
=2.2027

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Peterlabs Holdings Bhd has a Altman Z2-Score of 5.46 indicating it is in Safe Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 5.46 mean?
Peterlabs Holdings Bhd (XKLS:0171) has a Altman Z2-Score of 5.46 as of Jun. 29, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Peterlabs Holdings Bhd and its competitors. This is 20% below median its historical median of 6.81. Over the past decade, Peterlabs Holdings Bhd's Altman Z2-Score has ranged from 5.41 to 9.75. According to the industry distribution chart, Peterlabs Holdings Bhd ranks #355 out of 994 companies in the Drug Manufacturers industry, placing it in the top 35.7%.
Is Peterlabs Holdings Bhd's Altman Z2-Score too high?
Peterlabs Holdings Bhd's current Altman Z2-Score of 5.46 is 20% below median its 10-year median of 6.81. Over the past 10 years, this metric has ranged from a low of 5.41 to a high of 9.75. The Drug Manufacturers industry median Altman Z2-Score is 3.87. Peterlabs Holdings Bhd's value of 5.46 is 41.3% above this industry median. Based on the distribution chart, Peterlabs Holdings Bhd ranks #355 out of 994 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Peterlabs Holdings Bhd has a GF Score™ of 47/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Peterlabs Holdings Bhd's Altman Z2-Score compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Peterlabs Holdings Bhd ranks #355 out of 994 companies for Altman Z2-Score. This puts Peterlabs Holdings Bhd in the upper half of its industry. The industry median Altman Z2-Score is 3.87. Peterlabs Holdings Bhd's value of 5.46 is 41.3% above this benchmark. Historically, Peterlabs Holdings Bhd's own Altman Z2-Score has ranged from 5.41 to 9.75 over the past decade. While the company's 10-year median is 6.81 vs. the industry median of 3.87, Peterlabs Holdings Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Drug Manufacturers company?
The median Altman Z2-Score among Drug Manufacturers companies is 3.87, based on 994 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Peterlabs Holdings Bhd's current Altman Z2-Score of 5.46 is 41.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Peterlabs Holdings Bhd and its competitors. For the Drug Manufacturers industry, the median Altman Z2-Score is 3.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Peterlabs Holdings Bhd's current Altman Z2-Score is 5.46, which is 20% below median its own 10-year median of 6.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peterlabs Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Peterlabs Holdings Bhd (XKLS:0171) is currently considered Modestly Overvalued. The stock's GF Value™ is RM0.20, compared to a current price of RM0.24 — trading 20% above its estimated fair value. The current Altman Z2-Score is 5.46, which is 20% below median its 10-year median of 6.81 and 41.3% above the Drug Manufacturers industry median of 3.87. Peterlabs Holdings Bhd's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Peterlabs Holdings Bhd (XKLS:0171), the current Altman Z2-Score is 5.46 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Peterlabs Holdings Bhd (XKLS:0171) Overvalued in 2026?

Based on GuruFocus' analysis, Peterlabs Holdings Bhd stock appears to be overvalued. The current stock price of RM0.24 is trading 20% above its estimated GF Value™ of RM0.20. GuruFocus considers Peterlabs Holdings Bhd to be Modestly Overvalued.

Key valuation signals for XKLS:0171:

  • Altman Z2-Score: 5.46 (20% below median its 10-year median of 6.81)
  • GF Value™: RM0.20 vs. price of RM0.24 (20% above fair value)
  • GF Score™: 47/100 with 6 warning signs
  • Industry Position: 41.3% above the Drug Manufacturers median (#355 of 994)

No single metric tells the full story. See the XKLS:0171 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Peterlabs Holdings Bhd Business Description

Address Jalan Nilam 3, Lot 16014 (PT No. 24341), Bandar Nilai Utama, Nilai, NSN, MYS, 71800
Peterlabs Holdings Bhd is engaged in the manufacturing, distribution, export, and trading of animal health and nutrition products. The Group offers biosecurity and disinfectants, compound feed supplements, feed additives, nutritional premixes, pharmaceuticals, and water-soluble supplements, as well as farm management, technical advisory services, raw material analysis, and feed formulation. Its segments are Manufacturing, which covers the manufacturing and distribution of animal health and nutrition products; Trading, which involves the trading and distribution of animal health and nutrition products and consumer goods, and contributes the majority of its revenue; and Others, which provides investment holding services. The company operates in Malaysia and internationally.
47GF Score

Get the complete analysis for XKLS:0171

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.24
Price
RM0.20
GF Value